JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M300745200 on June 24, 2003

J. Biol. Chem., Vol. 278, Issue 36, 34467-34474, September 5, 2003
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/36/34467    most recent
M300745200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, C.
Right arrow Articles by Olsen, O.-A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, C.
Right arrow Articles by Olsen, O.-A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Calpain Domain of the Maize DEK1 Protein Contains the Conserved Catalytic Triad and Functions as a Cysteine Proteinase*

Cunxi Wang, Jennifer K. Barry, Zhao Min, Gabrielle Tordsen, A. Gururaj Rao and Odd-Arne Olsen {ddagger}

From the Pioneer Hi-Bred International, A DuPont Company, Johnston, Iowa 50131

Received for publication, January 22, 2003 , and in revised form, June 20, 2003.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Development of the aleurone layer of maize grains requires the activity of the Defective kernel 1 (Dek1) gene, encoding a predicted 240-kDa membrane-anchored protein with a C terminus similar to animal calpain domain II&III. Three-dimensional modeling shows that DEK1 domain II contains a conserved calpain catalytic triad and that domain II&III has a predicted structure similar to m-calpain. Recombinant DEK1 domain II&III exhibits activity in the caseinolytic assay in the absence of calcium, although the activity is enhanced by calcium. This is in sharp contrast to animal calpains, which require Ca2+ to be active. Bacterially expressed DEK1 domain II does not display caseinolytic activity, suggesting an important role for DEK1 domain III. Mutation of the catalytic Cys residue to Ser leads to a loss of caseinolytic activity of DEK1 domain II&III. Two features of DEK1 calpain may contribute to maintaining the active site triad in an "active" configuration in the absence of Ca2+, both of which are predicted to keep m-calpain domains IIa and IIb apart. First, DEK1 lacks key charged residues in the basic loop of domain II, and secondly, the absence of an acidic loop in domain III, both of which are predicted to be neutralized upon Ca2+ binding. The Dek1 transcript is present in all cell types in developing maize endosperm, suggesting that the activity of the DEK1 calpain is regulated at the post-transcription level. The role of DEK1 in aleurone signaling is discussed.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
In cereal grains, the aleurone layer consists of densely cytoplasmic cells covering the surface of the endosperm, the grain storage tissue that is used for feed, food and industrial raw material (1). Aleurone cells contain a large numbers of protein and oil bodies and are cytologically and biochemically distinct from the storage cells of the underlying starchy endosperm. Upon imbibition of the grain, aleurone cells secrete enzymes that mobilize stored starch and protein reserves for seedling growth (2). The endosperm develops from the central cell after double fertilization through a cellularization process that results in a peripheral layer of aleurone cell initials (3). From genetic evidence, the tumor necrosis factor receptor-like kinase CRINKLY4 (CR4) is implicated in aleurone cell fate specification (47). Based on the identity of the Cr4 gene product, as well as the peripheral position of the aleurone layer, we proposed a model in which the CR4 receptor is activated by a ligand in the periphery of the endosperm (8). Recently, we isolated the defective kernel 1 (dek1)1 gene, which is also essential for aleurone cell development (9). Homozygous recessive dek1 endosperm initiates aleurone cell fate specification, but fails to maintain aleurone cell fate, resulting in grains that lack aleurone cells (9). Revertant sector analysis has demonstrated that Dek1 function is essential for the maintenance of aleurone cell fate throughout grain development (10, 11). Sequence analysis predicts that the Dek1 gene encodes a 240 kDa protein with 21 membrane spanning domains and a cytoplasmic C terminus similar to animal calpain domains II&III (9). Based on BLAST analysis of the complete and near complete genomes of Arabidopsis thaliana and rice, respectively, as well as extensive EST collections in maize, the DEK1 calpain is the only member of the calpain gene superfamily in plants (9).

Calpains are a family of Ca2+-dependent cytosolic cysteine proteinases (12, 13) that consist of ubiquitous and tissue-specific isoforms in animals. Two mammalian calpains, m- and µ-calpain, are ubiquitously expressed and have been extensively characterized. Each of these forms a heterodimer comprising an 80-kDa catalytic subunit and a 30-kDa regulatory subunit. The µ- and m-isoforms differ in their in vitro requirements for Ca2+, the half-maximal activity in vitro for µ-calpain being 50 µM Ca2+ while m-calpain requires 300 µM Ca2+. The catalytic subunit of m-calpain is comprised of four domains; domain I which is involved in autolytic activation; domain II containing the catalytic triad residues (Cys-105, His-262, Asn-286 in m-calpain); domain III with similarity to a C2-domain and domain IV that has five EF-hand motifs (13, 14). The small, or regulatory subunit of calpain contains domain V, which is glycine- and proline-rich and domain VI that has several EF-hand motifs and is structurally very similar to domain IV of the catalytic subunit (15, 16).

More than a dozen calpain genes have been cloned and identified in animals. In addition to conventional calpain with a four domain structure, atypical calpains have been described where individual domains are replaced or deleted (1719). Some of these calpains appear to function as monomers and do not associate with a regulatory calpain subunit. These different properties indicate that individual isoforms of calpain are regulated differently and may have unique functions. The physiological role of calpain is determined by the function of the protein targeted for proteolysis. Various types of proteins such as transcription factors, calmodulin-binding proteins, components of receptor-mediated signal transduction and cytoskeletal proteins have been identified as calpain substrates in vitro or in vivo (2029). Calpains are reported to be involved in a wide range of cellular processes including cell proliferation, apoptosis, differentiation, and signal transduction. In addition, calpains have been implicated in endocytosis, exocytosis, and intracellular membrane fusion (30).

Although an understanding of calpain at the molecular, biochemical, and cellular levels has advanced greatly in animals since calpain was first described in 1964 (31), the functional significance of the DEK1 calpain in plants was not identified until 2001 (9). In maize, the phenotype of dek1 mutants suggests a role for Dek1 in global developmental regulation. In addition to the lack of aleurone cells, knockout of the Dek1 gene results in improper embryo axis formation and a missing shoot apical meristem (9). Also, as shown by mutant sector analysis, leaf differentiation, and in particular epidermis cell formation, requires Dek1 gene function (11). The predicted structure of DEK1 calpain suggests that it may function as a cysteine proteinase, and that its activity is regulated by extra cellular events mediated through the predicted membrane portion of the protein. In this study we investigate the structure of the calpain-like domain of DEK1 by using three-dimensional modeling and its biological activity by expressing recombinant DEK1 protein in bacteria. We also investigate the pattern of Dek1 transcript distribution in maize grains using in situ hybridization.


    EXPERIMENTAL PROCEDURES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Molecular Modeling of DEK1 Calpain Domains—The crystal structure of rat (Rattus norvegicus) m-calpain catalytic subunit (PDB 1DF0_A, 2.6 Å resolution) was used as a template to model the calpain domain of DEK1. Following a manual sequence alignment, the two proteins shared >30% sequence identity and >45% sequence similarity. Modeling studies were done on a SGI workstation with Modeler, an automated homology modeling program, using the Insight II software from Accelrys (San Diego, CA). Ten energy-minimized models were generated and three models with the lowest value of the objective function were further evaluated for appropriate stereochemistry using the Verify3D program (32). The model with the highest self-compatibility score in the Verify program was selected for the final study.

Cloning of cDNA Domains Encoding DEK1 Domain Proteins in Escherichia coli Expression Vectors—cDNA fragments corresponding to DEK1 calpain domains (9) were amplified by PCR. The flanking primers used for domain II&III and domain II were: 5'-GTCGACTTCACTGATCAAGAGTTCCCTC-3' with SalI site (forward) and 5'-GCGGCCGCTTAAACAGCCTCTAGTCTGATTGATG-3' with NotI site (reverse) and 5'-GTCGACTTCACTGATCAAGAGTTCCCTC-3' with SalI site (forward) and 5'-CGGCCGCTTAATAAACACGACAAACATATATTG-3' with NotI site (reverse), respectively. The cDNAs were ligated into pCR2.1 TOPO (Invitrogen) and then into pGEX-4T vector (Amersham Biosciences), which produced a glutathione S-transferase (GST) fusion at the N terminus. The recombinant plasmids were transformed into TOP 10 E. coli (Invitrogen). After insert sequences were verified by sequencing, the constructs were transformed into BL21 (DE3) E. coli (Invitrogen) for protein expression.

The Expression of DEK1 Domain II&III using Fermentation—The Dek1 domain II&III pGEX 4T-3 construct was transformed into BL21 Codon + RP cells (Stratagene). A 5-liter fermentor containing 5 liters of Terrific Broth (Yeast Extract 24 g/liter, pancreatic digest of casein 12 g/liter, dipotassium, phosphate 9.4 g/liter, monopotassium phosphate 2.2 g/liter, glycerol 4 ml/liter), 100 µg/ml carbenicillin, and 5 ml of antifoam (Mazu DF 204 Defoamer) was inoculated with 50 ml of overnight culture grown at 37 °C. The fermentation culture was grown at 37 °C until an OD600 of 1.0 was reached. The temperature was then lowered to 30 °C. The dissolved oxygen was maintained at greater than 30% throughout the run by controlling both stirring and airflow. The pH was maintained at 7.2 with NH4OH. The culture was induced with 0.1 mM IPTG (isopropyl-1-thio-{beta}-galactopyranoside) at an OD600 of 2.5. Three hours after induction, the cells were harvested by centrifugation at 10,000 x g for 20 min. A pellet from 1 liter of fermentation culture was resuspended in 20 ml of lysis buffer (50 mM Tris, pH 8.0, 200 mM NaCl, 5 mM dithiothreitol, Complete Proteinase Inhibitor (Roche Applied Science), lysozyme 1 mg/ml, bensonase 1 unit/ml) and lysed by sonication. Cell debris was removed by centrifugation at 10,000 x g for 5 min. The supernatant was incubated with glutathione Sepharose 4B beads prewashed with phosphate-buffered saline buffer containing 140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, and 1.8 mM KH2PO4 (pH 7.3) with gentle agitation at 4 °C for 0.5–1 h. Proteins bound to the beads were eluted with a buffer of 50 mM Tris-HCl (pH 8.0) and 10 mM reduced glutathione. The protein concentration was estimated by using a dye-binding protein assay kit (Bio-Rad) with bovine serum albumin as a standard.

The Expression of DEK1 Domain II—E. coli BL21 cell cultures were grown in LB medium (Difco Laboratories) with 100 µg/ml carbenicillin. The transformed cells harboring Dek1 domain II were grown at 37 °Cto an absorbance of ~1.0 at 600 nm. 5 ml of the cells were transferred into a 1-liter flask with 200 ml of LB medium containing 0.1 mM IPTG and incubated overnight at 18 °C. The cells were then harvested for the GST-DEK1 domain II purification as mentioned above.

Site-directed Mutagenesis of DEK1—Site-directed mutagenesis of DEK1 domain protein was generated by a PCR-based overlapping method described by Ho et al. (33). The flanking primers were the same as those used for domain II&III. The internal primers used for generation of mutant were 5'-TCGGTTGGGAGACTCTTGGTTCCTAAGTG-3' and 5'-CACTTAGGAACCAAGAGTCTCCCAACCGA-3' (altered codon is underlined). The mutation was verified by sequencing.

DEK1 Activity Assay—The method used to determine the proteolytic activity of DEK1 domains is based on an electrophoretic casein degradation assay used in previous studies of animal m-clapain (34). In our assays, a typical reaction contained 2 µg of DEK1 domain protein, 3 µg of purified {beta}-casein (Sigma-Aldrich C6905, more than 90% purity) in 20 µl of reaction buffer (50 mM imidazole-HCl, pH 7.5, 10 mM {beta}-mercaptoethanol). Reaction mixtures were incubated at 30 °C for a variable time interval. The reaction was stopped by adding NuPAGE LDS sample buffer (Invitrogen). After incubation at 70 °C for 10 min, the mixture was separated by a NuPAGE 10% bis-tris gel and then stained with Colloidal Blue kit (Invitrogen). Change in the intensity of the {beta}-casein band was used to quantify DEK1 proteolytic activity. Three independent assays were carried out to calculate standard deviation (S.D.) in these assays. Intensity was measured by using the ChemiDoc system (Bio-Rad).

CD Studies—CD spectra were measured using a Jasco J-715 model spectropolarimeter. Far-UV spectra were recorded from 190 to 260 nm in a 0.1 mm pathlength quartz cuvette. Protein was dialyzed into 35 mM potassium phosphate buffer (pH 7.6) and diluted to a concentration of 0.3 mg/ml. Data are reported as mean residue ellipticity. In Situ Hybridization Analysis—Digoxigenin-11-UTP-labeled RNA probes were used to localize Dek1 mRNA in cells according to the protocol described by Jackson (35). RNA probes were made using Digoxigenin-11-UTP labeled NTP mixture with SP6 and T7 RNA polymerases (Roche Applied Science). The 721-bp fragment of 3'-region Dek1 cDNA was subcloned into pSPORT I vector (Invitrogen). The clone was linearized by XbaI (sense) and PstI (antisense) and transcribed into RNA in vitro. Unincorporated ribonucleotides were removed using Qiagen RNeasy purification kit and probes were subjected to carbonate hydrolysis in order to reduce probe length to ~150 nucleotides. Microscopy evaluation was carried out in dark field using a Nikon Eclipse E800 microscope.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Molecular and Structural Features of DEK1—Searching plant databases using the maize Dek1 sequence (9) identified several Dek1 orthologues in other plant species, including rice, Arabidopsis, sugarcane, sorghum, and soybean. Sequence analysis indicated that DEK1 proteins from different plant species are highly conserved, sharing 70–98% sequence identity (Table I). All plant species investigated were found to have a single copy of Dek1. Structurally, the deduced DEK1 sequence can be divided into several domains, including two transmembrane domains (B1 and B2), an extracellular loop region (C), a hydrophilic and charged domain (D), domain II and domain III as described previously (9). In addition, there is a predicted membrane targeting signal sequence located at the N terminus. Domain B1, B2, C, and D show no significant amino acid sequence similarity to any other sequences in databases, and their functions remain unknown. In the C terminus, the amino acid sequence of maize DEK1 domain II&III shares about 40–50% similarity and 30 to 40% identity to that of the same domains of animal calpains. To establish the evolutionary relationship among animal calpains and plant DEK1 proteins, a phylogenetic tree was constructed using domain II and III (Fig.1). This analysis suggests that DEK1 domain II&III is evolutionarily most closely related to the animal SOL (small optic lobes) and SOLH (SOL homologue from humans) calpains.


View this table:
[in this window]
[in a new window]
 
TABLE I
Amino acid sequence similarities among plant DEK1 orthologues

The comparison was generated by the Gap program in GCG (Wisconsin package).

 


View larger version (15K):
[in this window]
[in a new window]
 
FIG. 1.
Phylogenetic relationship between DEK1 and its calpain orthologues. The tree was constructed from amino acid sequences by using the GrowTree program from the GCG. Accession numbers are listed in the figure. m-Calpain is listed as calpain2.

 

Amino acid sequence alignment of DEK1 calpain and mcalpain demonstrates a conserved domain organization for domain II and domain III (Fig. 2). Indeed, this architecture appears to be remarkably well conserved even in the modeled three-dimensional structure of the protein (Fig. 3A). In addition to the overall fold, the conservation and arrangement of residues important for catalysis and substrate binding in domain II are particularly significant. As in m-calpain, the catalytic Cys-71 (Cys-105 in m-calpain) is located in the {alpha}-helix of domain IIa, on the opposite side of the interface with domain IIb which harbors the two other residues of the catalytic triad, His-229 and Asn-249 (corresponding to His-262 and Asn-286 in m-calpain, Fig. 2). Importantly, the distance of ~10.3 Å between the catalytic Cys S{gamma} and the His N{delta} 1 in the model compares favorably with the ~10.5 Å measurement for the same atoms in the calcium-free conformation of m-calpain (14, 36) and validates the modeled structure. Additional residues conserved within the context of the active-site cleft comprising the subdomains of the catalytic domain include Gln-65, Trp-72, Gly-160–161, Pro-250, and Trp-251 (Fig. 3B). Despite this strong conservation in domain II, however, there are two significant differences to be noted in domain III between m-calpain and DEK1. First, while the basic loop comprising residues His-415-His-427 of m-calpain contains 4 Args and 1 Lys, the corresponding loop in DEK1 (residues 371–383 in Fig. 2) contains just one Arg residue. Even more importantly, in contrast to the very acidic loop of m-calpain (residues 392–402) consisting of 10 negatively charged residues, there is just one conserved Asp-347 in the DEK1 loop (residues 344–354 in Fig. 2; asterisk in Fig. 3A).



View larger version (42K):
[in this window]
[in a new window]
 
FIG. 2.
Structure-sequence alignment of DEK1 calpain and m-calpain (1DF0 [PDB] ). In DEK1 calpain domain II&III Lys-1 corresponds to Lys-1699 in the full-length DEK1 protein sequence. Catalytic residues are indicated by triangles. Lowercase letters indicate amino acid residues not resolved in the structure of m-calpain. Specific amino acids in m-calpain are represented by the following: acidic amino acids by arrows, basic amino acids by underline and conserved substrate binding residues by asterisks. The m-calpain Protein Data Bank entry used in the alignment was 1DF0 [PDB] which contains an introduced mutation of the active site Cys-105 to Ser (Ref. 14, accession: NP_058812 [GenBank] ).

 


View larger version (30K):
[in this window]
[in a new window]
 
FIG. 3.
Three-dimensional modeling of DEK1 calpain. A, modeled structure of DEK1 calpain showing the active site residues Cys-71, His-229, Asn-249. The individual domains are color-coded. The acidic loop region of domain III is indicated by an asterisk. B, other conserved residues in the vicinity of the active site: Gln-65, Trp-72, Gly-160–161, Pro-250, and Trp-251. Figure prepared with the program MOLMOL (45).

 

Expression and Purification of Recombinant DEK1 Wild-type and Mutated Domain Proteins—The partial cDNAs encoding DEK1 domain II&III and domain II alone were cloned into pGEX-4T-3 vector to produce the corresponding GST fusion proteins in E. coli. Under conditions normally used to express fusion proteins in E. coli, the majority of the expressed DEK1 domain II&III protein appears in inclusion bodies. Production of the wild-type and mutant (see below) versions of DEK1 domain II&III was therefore carried out by fermentation, yielding a significant amount of soluble domain II&III protein. The expressed DEK1 domain II&III protein was purified to near homogeneity with glutathione-Sepharose 4B beads (Fig. 4A). In contrast to DEK1 domain II&III protein, DEK1 domain II appears both in soluble and insoluble forms under standard expression conditions (Fig. 4A). The identity of the purified protein was confirmed by immunoblotting using an antibody raised against GST and by measuring GST activity (data not shown).



View larger version (24K):
[in this window]
[in a new window]
 
FIG. 4.
Purification of DEK1 domain proteins. A, colloidal blue staining of partially purified DEK1 domain proteins separated on a 10% NuPAGE gel. DEK1 domain proteins were expressed in E. coli as GST-fusions. II&III: DEK1 domain II&III, II: DEK1 domain II. 1 µg of purified protein was loaded per lane. B, CD spectra of recombinant wild-type and mutant DEK1 domain proteins. CD spectra of DEK1 domain II&III (closed square), domain II (open circle), and domain II&III mutant protein (closed triangle).

 

The far-UV CD spectra demonstrate that DEK1 domain II&III, domain II and a mutant, C71S, of the DEK1 domain II&III protein all have a similar secondary structure (see below for details on the mutant protein) (Fig. 4B). These results indicated that no gross structural rearrangements had occurred in the mutated protein.

Characterization of DEK1 Domain II&III Proteinase Activity—The proteolytic activity of DEK1 domain II&III was tested in an assay in which purified {beta}-casein (Fig. 5A, lane 2) was incubated with the DEK1 domain II&III protein under various conditions (Fig. 5A, lane 3). In the presence of 5 mM Ca2+, casein degradation leveled off after approximately 9 h of incubation (Fig. 5A, lanes 4–9). This result suggests that DEK1 domain II&III possesses an activity that is similar to that of m-calpain. Surprisingly, however, DEK1 domain II&III also displays a strong proteolytic activity in the absence of Ca2+. The same proportion of {beta}-casein was degraded after 9 h as in the presence of Ca2+ (Fig. 5A, lanes 10–15). Notably, in the presence of Ca2+, DEK1 proteolysis of casein produced two bands after 5 h of incubation (Fig. 5A, lane 6). In the absence of Ca2+, the second breakdown product (lower molecular weight) appeared as a weak band only after 12 h of incubation (Fig. 5A, lane 15). From these observations we conclude that Ca2+ acts as an activator of DEK1 in this in vitro assay. Incubating casein with different concentrations of purified DEK1 domain II&III demonstrates that the casein degradation is concentration dependent (Fig. 5, C and D).



View larger version (26K):
[in this window]
[in a new window]
 
FIG. 5.
Activity of bacterially expressed DEK1 domain II&III. A, DEK1 domain II&III (2 µg) was incubated with {beta}-casein (3 µg) in the presence of 5 mM Ca2+ (lanes 4–9)or2mM EDTA (lanes 10–15)at30 °C for the time indicated in the figure. The reaction mixture was separated by 10% NuPAGE and stained by Colloidal Blue. Lane 1, molecular marker; lane 2, {beta}-casein; lane 3, domain II&III alone. Arrowhead and arrow indicate the DEK1 domain II&III and {beta}-casein, respectively. B, the time course of {beta}-casein degradation (band marked by arrow) in the presence of 5 mM Ca2+ (solid line) or 2 mM EDTA (broken line). Error bars (S.D.) were calculated based on quantitation of three independent assays. C, dependence of {beta}-casein degradation (band marked by arrow) on DEK1 domain II&III concentration. Reaction mixture was incubated at 30 °C for 7 h. Lanes 1, 2, and 3, 0.5, 1, 2 µg of DEK1 domain II&III, respectively. Arrowhead and arrow indicate the DEK1 domain II&III and {beta}-casein, respectively. D, degradation of {beta}-casein (band marked by arrow) as a function of increasing concentration of DEK1 domain II&III protein. Error bars (S.D.) were calculated as described above.

 

Role of Cys-71 in DEK1 Domain II&III Proteolytic Activity— The sequence alignment of DEK1 and m-calpain predicts that Cys-71 is an active site residue of the catalytic triad. To verify whether or not DEK1 is a true cysteine proteinase, we created a mutant in which the Cys-71 was replaced with Ser as was previously done for animal calpains (37, 38). The mutant protein was expressed and purified in the same manner as wild-type DEK1 domain II&III protein. This mutation did not cause secondary structural rearrangements as evidenced by the CD spectrum (Fig. 4B). Activity measurements show that the mutant protein is inactive compared with the wild-type protein (Fig. 6A, lanes 4 and 5). This loss of activity clearly identifies the mutated cysteine as part of the active triad of the DEK1 domain II protein, and is in agreement with previous reports showing that the same mutation in m-calpain abolishes this activity. To evaluate the effect of DEK1 domain III on the proteinase activity of DEK1 domain II&III, DEK1 domain II alone was incubated with {beta}-casein. This experiment showed that in vitro DEK1 domain II alone was inactive (Fig. 6B, lane 6), demonstrating that domain III is necessary for DEK1 proteolytic activity.



View larger version (55K):
[in this window]
[in a new window]
 
FIG. 6.
Dependence of DEK1 proteolytic activity on Cys-71 active site residue and domain III. A, purified mutant protein (C71S, 2 µg) was incubated with {beta}-casein (3 µg) in the presence of 5 mM Ca2+ at 30 °C for 7 h (lane 5). The mixture was separated by 10% NuPAGE and stained by Colloidal Blue. Lane 1, molecular marker; lane 2, {beta}-casein; lane 3, mutated domain II&III alone (mutant C71S); lane 4, wild-type domain II&III was incubated with {beta}-casein (3 µg) in the presence of 5 mM Ca2+ at 30 °C for 7 h. B, DEK1 domain II protein (2 µg) was incubated with {beta}-casein (3 µg) in the presence of 5 mM Ca2+ at 30 °C for 9 h (lane 6). The reaction mixture was separated by 10% NuPAGE and stained by Colloidal Blue. Lane 1, molecular marker; lane 2, {beta}-casein; lane 3, GST; lane 4, GST was incubated with {beta}-casein; lane 5, DEK1 domain II only. Arrowhead and arrow indicate DEK1 domain II and {beta}-casein, respectively.

 

Expression of Dek1 in Maize Grains—As shown previously, the Dek1 transcript is present at a low level in most plant tissues (9). To determine if Dek1 mRNA shows an aleurone preferred pattern of expression in endosperm, we carried out in situ hybridization experiments using sections from various grain developmental stages. These experiments show that the Dek1 transcript is detectable in all grain cell types, including the maternal pericarp, aleurone cells, and the starchy endosperm (Fig. 7, A and B). This result corresponds well with the previously reported LYNX MPSS data (9), suggesting that the activity of DEK1 in the aleurone layer is post-transcriptionally regulated.



View larger version (74K):
[in this window]
[in a new window]
 
FIG. 7.
In situ hybridization using Dek1 mRNA as a probe. A, antisense probe; B, sense (control) probe. AL, aleurone layer; P, pericarp; S.E., starchy endosperm.

 


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Two sets of data presented in this paper support the conclusion that Dek1 encodes a functional member of the calpain super-family of proteins. First, sequence alignment and three-dimensional modeling show a significant sequence and structure similarity between DEK1 and animal calpain (Figs. 2 and 3). Secondly, recombinant DEK1 calpain is active in the caseinolytic assay previously used for animal calpains, and this activity is abolished by changing the cysteine of the active site triad to serine (Figs. 4, 5, 6).

Regulation in vivo of conventional animal calpains such as m-calpain is complex, and operates at several levels, including signal transduction, Ca2+ activation, subcellular relocation from cytosol to, or near, the plasma membrane, interaction with phospholipids, autocatalytic cleavage, and interaction with a regulatory small subunit. Extensive studies of the three-dimensional structure of m-calpain and other members of this cysteine proteinase family have revealed that the inactive ground state of the enzyme is one in which the amino acids of the catalytic triad are sterically separated. Calcium binding induces a conformational change that assembles the catalytic triad of residues into its active conformation (14, 36). In m-calpain, activation involves a series of events including a relief of the conformational restraint imposed by the interaction between domain I of the large subunit and the penta-EF-hand domain VI of the regulatory subunit. Concomitantly, Ca2+-induced conformational changes in domain IV are transduced via domain III to the proteinase domain, domain II (39, 40). These structural features include an acidic loop consisting of 10 negatively charged residues in domain III that makes direct contact with domain II (13, 40, 41). The negative electrostatic potential in the loop is somewhat counterbalanced by interdomain salt bridges between some of the negatively charged residues and the basic residues in domain II, including the Lys residues at positions 226, 230, 234, 354, 355, and 357 (Fig. 2). Furthermore, it has been hypothesized that domain III itself can bind calcium at this negative cluster, thereby further lowering the strongly negative potential. The role of calcium binding in this model is to drive the conformational change that simultaneously overcomes the considerable steric hindrance from the Pro-287–Trp-288 loop in the active site interface and permits movement of domains IIa and domains IIb toward each other to "fuse" into the catalytically active domain. In this state, where the competent catalytic triad is reassembled, the Cys S{gamma} -His N{delta} 1 is reduced to ~3.7 Å. This model explains why recombinant conventional animal m-calpain is inactive in the absence of calcium, as well as the underlying mechanism for the calcium-dependent activation of the enzyme.

The lack of measurable activity of DEK1 domain II presented here is in accordance with the result reported for m-calpain domain II, showing less than 1% of full-length m-calpain activity (34). The similar characteristics of domain II from m-calpain and DEK1 appear reasonable considering the high similarity in their predicted structures (Fig. 3). In contrast, recombinant DEK1 domain II&III displayed significant activity in the absence of calcium, a characteristic that differs dramatically from that of m-calpain. In our interpretation of the DEK1 calpain 3D model (Fig. 3), the lack of an absolute calcium requirement for DEK1 calpain activity may be attributed to a ground state for the enzyme in which the catalytic triad is assembled close to its optimal configuration for activity. As mentioned above, several features of DEK1 calpain contribute to our conjecture. First, it has been suggested that a cluster of 4 negatively charged residues in m-calpain, Asp-96, Glu-172, Glu-320, and Glu-321 provide a strong repulsive force that prevents domains IIa and IIb from coming together and that charge compensation through calcium binding relieves this repulsive force and facilitates the fusion of the catalytic domain (41). In DEK1 calpain, only Asp-62 (corresponding to Asp-96 in m-calpain) is conserved, suggesting that this repulsive force is not operating in DEK1 calpain, thus making charge-compensation by calcium binding less needed. Secondly, DEK1 domain III is missing 9 of the 10 negatively charged residues in the loop corresponding to the acidic loop of m-calpain. Furthermore, key Lys residues at positions 226, 230, 234, 354, 355, and 357 of m-calpain are also absent in DEK1 domain III, making it unlikely that this domain can bind calcium and thereby regulate calpain activity (Fig. 2). We suggest that the increase in DEK1 calpain activity when calcium is added is probably caused by a slight repositioning of domain IIa and IIb, leading to an optimalization of the catalytic triad configuration. The mechanism, as well as the biological role of Ca2+ activation in DEK1 calpain functioning remains to be determined.

In addition to domain II&III discussed above, the conventional Ca2+-dependent calpain holoenzymes consist of a domain I and an EF-hand domain IV, as well as a regulatory small subunit. Animal calpains, however, are a diverse group of proteins with domain II as the main conserved feature. In addition, most calpains, including DEK1 have domain III. There are, however, exceptions to this rule, as calpain 10 lacks a penta-EF-hand domain, while neither a C2-like domain nor a penta-EF-hand domain is present in SOL or in SOLH (13). So far, a calcium requirement for calpain 10 or SOL has not been reported (17, 18), Interestingly, in the animal calpain super-family, the acidic loop exhibits high sequence diversity in terms of the number of negatively charged residues (see discussion above, Ref. 13). This variability may provide a plausible explanation for the differences in calcium sensitivities among members of the calpain family, also raising the possibility that some animal calpains may act in a Ca2+-independent manner.

In contrast to the diversified structure of animal calpains, plants appear to possess only one member of the calpain super family, namely DEK1, showing a high degree of conservation among plant species (9). Similar to animal calpains, the catalytic domain II of plant DEK1 homologues is the most highly conserved domain. For example, domain II, which is 302 amino acids long, is 100% identical between maize and sugarcane. A comparison of domain II sequences between maize and loblolly pine, a gymnosperm, reveals 79% similarity (9). The high conservation between all these sequences suggests an important function for the DEK1 protein in all plants. Most notably, DEK1 calpain represents the C-terminal domain of a 240-kDa protein that is predicted to be anchored in the plasma membrane by 21 transmembrane segments interrupted by a putative extra cytosolic loop domain (9). A membrane-anchoring domain is unusal for animal calpains, which mostly are cytosolic enzymes that are translocated to the plasma membrane upon activation (42, 43). The only known example of an animal calpain with a predicted membrane anchor is the Drosophila calpain CG3692 that has a transmembrane domain structure similar to DEK1 calpain. The calpain domains are linked to the membrane part of the DEK1 protein by a 600 amino acid segment with few recognizable features.

The Dek1 gene plays an important role in plant development, being essential for the proper development of the aleurone layer in maize grains, embryo shoot apical meristem function as well as leaf epidermis formation (14, 36). A second gene known to function in signal transduction in the same tissues is the TNFR-like receptor like kinase CR4 (4, 5). Recently, we cloned a third gene implicated in the same developmental pathways, Superal1 (supernumerary aleurone layer 1), encoding a plant homologue of CHMP1, a member of the E-vacuolar protein sorting family (44). This finding may suggest that regulation of aleurone cell fate involves CR4 receptor internalization through endosome trafficking and targeted proteolysis in vacuoles. Interestingly, animal calpains have been implicated in vesicle trafficking, including the formation of coated vesicles and vesicle fusion to endosomes (30). One possibility, therefore, is that DEK1 functions in the endosome trafficking pathway by modifying membrane proteins participating in the formation and targeted transport of membrane vesicles. The in situ hybridization results presented here suggest that Dek1 is transcribed in all cell types, despite the fact that in the endosperm, Dek1 function is essential only in the aleurone layer (9). We are currently exploring the possibility that the DEK1 calpain is activated only in epidermal cell layers mediated through interaction(s) between the predicted extracellular loop region of DEK1 and extracellular factors.


    FOOTNOTES
 
* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

{ddagger} To whom correspondence should be addressed. Tel.: 515-253-2417; Fax: 515-254-2619; E-mail: odd-arne.olsen{at}pioneer.com.

1 The abbreviations used are: dek1, defective kernel 1 gene; GST, glutathione S-transferase; DAP, days after pollination; IPTG, isopropyl-1-thio-{beta}-D-galactopyranoside. Back



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Olsen, O.-A. (2001) Annu. Rev. Plant Physiol. Plant Mol. Biol. 52, 233–267[CrossRef][Medline] [Order article via Infotrieve]
  2. Ritchie, S., and Gilroy, S. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 2697–2702[Abstract/Free Full Text]
  3. Brown, R. C., Lemon, B. E., and Olsen, O.-A. (1994) Plant Cell 6, 1241–1252[Abstract]
  4. Becraft, P. W., Stinard, P. S., and McCarty, D. R. (1996) Science 273, 1406–1409[Abstract]
  5. Becraft, P. W., Kang, S. H., and Suh, S. G. (2001) Plant Physiol. 127, 486–496[Abstract/Free Full Text]
  6. Becraft, P. W. (2002) Annu. Rev. Cell Dev. Biol. 18, 163–192[CrossRef][Medline] [Order article via Infotrieve]
  7. Tanaka, H., Watanabe, M., Watanabe, D., Tanaka, T., Machida, C., and Machida, Y. (2002) Plant Cell Physiol. 43, 419–428[Abstract/Free Full Text]
  8. Olsen, O.-A., Lemmon, B. E., and Brown, R. C. (1998) Trends Plant Sci. 3, 168–169[CrossRef]
  9. Lid, S. E., Gruis, D., Jung, R., Lorentzen, J. A., Ananiev, E., Chamberlin, M., Niu, X., Meeley, R., Nichols, S., and Olsen, O.-A. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 5460–5465[Abstract/Free Full Text]
  10. Becraft, P. W., and Asuncion-Crabb, Y. (2000) Development 127, 4039–4048[Abstract]
  11. Becraft, P. W., Li, K., Dey, N., and Asuncion-Crabb, Y. (2002) Development 129, 5217–5225[Medline] [Order article via Infotrieve]
  12. Sorimachi, H., Ishiura, S., and Suzuki, K. (1997) Biochem. J. 328, 721–732[Medline] [Order article via Infotrieve]
  13. Sorimachi, H., and Suzuki, K. (2001) J. Biochem. 129, 653–664[Abstract/Free Full Text]
  14. Hosfield, C. M., Elce, J. S., Davies, P. L., and Jia, Z. (1999) EMBO J. 18, 6880–6889[CrossRef][Medline] [Order article via Infotrieve]
  15. Xie, X., Dwyer, M. D., Swenson, L., Parker, M. H., and Botfield, M. C. (2001) Protein Sci. 10, 2419–2425[Abstract/Free Full Text]
  16. Schad, E., Farkas, A., Jekely, G., Tompa, P., and Friedrich, P. (2002) Biochem. J. 362, 383–388[CrossRef][Medline] [Order article via Infotrieve]
  17. Ma, H., Fukiage, C., Kim, Y. H., Duncan, M. K., Reed, N. A., Shih, M., Azuma, M., and Shearer, T. R. (2001) J. Biol. Chem. 276, 28525–28531[Abstract/Free Full Text]
  18. Laval, M., and Pascal, M. (2002) Biochim. Biophys. Acta 1570, 121–128[Medline] [Order article via Infotrieve]
  19. Futai, E., Kubo, T., Sorimachi, H., Suzuki, K., and Maeda, T. (2001) Biochim. Biophy. Acta 1517, 316–319[Medline] [Order article via Infotrieve]
  20. Aragon, B., Poussard, S., Dulong, S., Touyarot, K., Dargelos, E., Brustis, J., Levieux, D., Ducastaing, A., and Cottin, P. (2002) Mol. Cell Biochem. 231, 97–106[CrossRef][Medline] [Order article via Infotrieve]
  21. Gil-Parrado, S., Fernandez-Montalvan, A., Assfalg-Machleidt, I., Popp, O., Bestvater, F., Holloschi, A., Knoch, T. A., Auerswald, E. A., Welsh, K., Reed, J. C., Fritz, H., Fuentes-Prior, P., Spiess, E., Salvesen, G. S., and Machleidt, W. (2002) J. Biol. Chem. 277, 27217–27226[Abstract/Free Full Text]
  22. Lee, M., Kwon, Y., Li, M., Peng, J., Friedlander, R., and Tsai, L. (2000) Nature 405, 360–364[CrossRef][Medline] [Order article via Infotrieve]
  23. Schoenwaelder, S. M., Kulkarni, S., Salem, H. H., Imajoh-Ohmi, S., Yamao-Harigaya, W., Saido, T. C., and Jackson, S. P. (1997) J. Biol. Chem. 272, 24876–24884[Abstract/Free Full Text]
  24. Noguchi, M., Sarin, A., Aman, M. J., Nakajima, H., Shores, E. W., Henkart, P. A., and Leonard, W. J. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 11534–11539[Abstract/Free Full Text]
  25. Han, Y., Weinman, S., Boldogh, I., Walker, R. K., and Brasier, A. R. (1999) J. Biol. Chem. 274, 787–794[Abstract/Free Full Text]
  26. Kulkarni, S., Goll, D. E., and Fox, J. E. B. (2002) J. Biol. Chem. 277, 24435–24441[Abstract/Free Full Text]
  27. Bordone, L., and Campbell, C. (2002) J. Biol. Chem. 277, 26673–26680[Abstract/Free Full Text]
  28. Amano, S., Kawasaki, H., Ishiura, S., Kawashima, S., Suzuki, K., and Emori, Y. (1997) J. Biochem. 122, 865–871[Abstract/Free Full Text]
  29. Benetti, R., Del Sal, G., Monte, M., Paroni, G., Brancolini, C., and Schneider, C. (2001) EMBO J. 20, 2702–2714[CrossRef][Medline] [Order article via Infotrieve]
  30. Sato, K., Saito, Y., and Kawashima, S. (1995) Eur. J. Biochem. 230, 25–31[Medline] [Order article via Infotrieve]
  31. Guroff, G. (1964) J. Biol. Chem. 239, 149–155[Free Full Text]
  32. Luthy, R., Bowie, J. U., and Eisenberg, D. (1992) Nature 356, 83–85[CrossRef][Medline] [Order article via Infotrieve]
  33. Ho, S. N., Hunt, H. D., Horton, R. M., Pullen, J. K., and Pease, L. R. (1989) Gene (Amst.) 77, 51–59[CrossRef][Medline] [Order article via Infotrieve]
  34. Hata, S., Sorimachi, H., Nakagawa, K., Maeda, T., Abe, K., and Suzuki, K. (2001) FEBS Lett. 501, 111–114[CrossRef][Medline] [Order article via Infotrieve]
  35. Jackson, D. P. (1992) in Molecular Plant Pathology: A Practical Approach (Bowles, D. J., Gurr, S. J., and McPherson, M, ed) pp. 163–174, Oxford University Press, Oxford
  36. Strobl, S., Fernandez-Catalan, C., Braun, M., Huber, R., Masumoto, H., Nakagawa, K., Irie, A., Sorimachi, H., Bourenkow, G., Bartunik, H., Suzuki, K., and Bode, W. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 588–592[Abstract/Free Full Text]
  37. Masumoto, H., Yoshizawa, T., Sorimachi, H., Nishino, T., Ishiura, S., and Suzuki, K. (1998) J. Biochem. 124, 957–961[Abstract/Free Full Text]
  38. Arthur, J. S. C., Gauthier, S., and Elce, J. S. (1995) FEBS Lett. 368, 397–400[CrossRef][Medline] [Order article via Infotrieve]
  39. Dutt, P, A. J., Grochulski, P., Cygler, M., and Elce, J. S. (2000) Biochem. J. 384, 37–43
  40. Dutt, P. S. C., Davies, P. L., Jia, Z., and Elce, J. S. (2002) Biochem. J. 367, 263–269[CrossRef][Medline] [Order article via Infotrieve]
  41. Hosfield, C. M., Moldoveanu, T., Davies, P. L., Elce, J. S., and Jia, Z. (2001) J. Biol. Chem. 276, 7404–7407[Abstract/Free Full Text]
  42. Sazontova, T. G., Matskevich, A. A., and Arkhipenko, Y. V. (1999) Pathophysiology 6, 91–102[Medline] [Order article via Infotrieve]
  43. Sato, K., and Kawashima, S. (2001) Biol. Chem. 382, 743–751[CrossRef][Medline] [Order article via Infotrieve]
  44. Shen, B., Li, C., Min, Z., Meeley, R., Tarczinsky, M., and Olsen, O.-A. (2003) Proc. Natl. Acad. Sci. U. S. A. 100, 6552–6557[Abstract/Free Full Text]
  45. Koradi, R., Billeter, M., and Wuthrich, K. (1996) J. Mol. Graphics 14, 51–55[CrossRef][Medline] [Order article via Infotrieve]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J Exp BotHome page
L. T. Olsen, H. H. Divon, R. Al, K. Fosnes, S. E. Lid, and H.-G. Opsahl-Sorteberg
The defective seed5 (des5) mutant: effects on barley seed development and HvDek1, HvCr4, and HvSal1 gene regulation
J. Exp. Bot., October 1, 2008; 59(13): 3753 - 3765.
[Abstract] [Full Text] [PDF]


Home page
Plant CellHome page
Q. Tian, L. Olsen, B. Sun, S. E. Lid, R. C. Brown, B. E. Lemmon, K. Fosnes, D. Gruis, H.-G. Opsahl-Sorteberg, M. S. Otegui, et al.
Subcellular Localization and Functional Domain Studies of DEFECTIVE KERNEL1 in Maize and Arabidopsis Suggest a Model for Aleurone Cell Fate Specification Involving CRINKLY4 and SUPERNUMERARY ALEURONE LAYER1
PLANT CELL, October 1, 2007; 19(10): 3127 - 3145.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Jacob-Wilk, I. Kurek, P. Hogan, and D. P. Delmer
The cotton fiber zinc-binding domain of cellulose synthase A1 from Gossypium hirsutum displays rapid turnover in vitro and in vivo
PNAS, August 8, 2006; 103(32): 12191 - 12196.
[Abstract] [Full Text] [PDF]


Home page
Plant Physiol.Home page
D. Gruis, H. Guo, D. Selinger, Q. Tian, and O.-A. Olsen
Surface Position, Not Signaling from Surrounding Maternal Tissues, Specifies Aleurone Epidermal Cell Fate in Maize
Plant Physiology, July 1, 2006; 141(3): 898 - 909.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
J. Zhang and T. Peterson
A Segmental Deletion Series Generated by Sister-Chromatid Transposition of Ac Transposable Elements in Maize
Genetics, September 1, 2005; 171(1): 333 - 344.
[Abstract] [Full Text] [PDF]


Home page
Plant Physiol.Home page
J. Geisler-Lee and D. R. Gallie
Aleurone Cell Identity Is Suppressed following Connation in Maize Kernels
Plant Physiology, September 1, 2005; 139(1): 204 - 212.
[Abstract] [Full Text] [PDF]


Home page
Plant Physiol.Home page
I. Tzafrir, R. Pena-Muralla, A. Dickerman, M. Berg, R. Rogers, S. Hutchens, T. C. Sweeney, J. McElver, G. Aux, D. Patton, et al.
Identification of Genes Required for Embryo Development in Arabidopsis
Plant Physiology, July 1, 2004; 135(3): 1206 - 1220.
[Abstract] [Full Text] [PDF]


Home page
Plant CellHome page
O.-A. Olsen
Nuclear Endosperm Development in Cereals and Arabidopsis thaliana
PLANT CELL, June 1, 2004; 16(suppl_1): S214 - S227.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/36/34467    most recent
M300745200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted